230 related articles for article (PubMed ID: 34485172)
1. Pharmacokinetics and Pharmacodynamics of a Novel Virulent Klebsiella Phage Kp_Pokalde_002 in a Mouse Model.
Dhungana G; Nepal R; Regmi M; Malla R
Front Cell Infect Microbiol; 2021; 11():684704. PubMed ID: 34485172
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic Efficacy of Bacteriophage Therapy to Treat Carbapenem Resistant Klebsiella Pneumoniae in Mouse Model.
Dhungana G; Regmi M; Paudel P; Parajuli A; Upadhyay E; Gyawali I; Upreti H; Nepal R; Pradhan P; Malla R
J Nepal Health Res Counc; 2021 Apr; 19(1):76-82. PubMed ID: 33934137
[TBL] [Abstract][Full Text] [Related]
3. [Biological characteristics and genomic information of a bacteriophage against pan-drug resistant
Qi ZY; Yang SY; Dong SW; Zhao FF; Qin JH; Xiang J
Zhonghua Shao Shang Za Zhi; 2020 Jan; 36(1):14-23. PubMed ID: 32023713
[No Abstract] [Full Text] [Related]
4. Phage therapy for treatment of virulent Klebsiella pneumoniae infection in a mouse model.
Anand T; Virmani N; Kumar S; Mohanty AK; Pavulraj S; Bera BC; Vaid RK; Ahlawat U; Tripathi BN
J Glob Antimicrob Resist; 2020 Jun; 21():34-41. PubMed ID: 31604128
[TBL] [Abstract][Full Text] [Related]
5. Phages against Noncapsulated Klebsiella pneumoniae: Broader Host range, Slower Resistance.
Lourenço M; Osbelt L; Passet V; Gravey F; Megrian D; Strowig T; Rodrigues C; Brisse S
Microbiol Spectr; 2023 Aug; 11(4):e0481222. PubMed ID: 37338376
[TBL] [Abstract][Full Text] [Related]
6. Evidence to support the therapeutic potential of bacteriophage Kpn5 in burn wound infection caused by Klebsiella pneumoniae in BALB/c mice.
Kumari S; Harjai K; Chhibber S
J Microbiol Biotechnol; 2010 May; 20(5):935-41. PubMed ID: 20519918
[TBL] [Abstract][Full Text] [Related]
7. Bacteriophage Treatment Rescues Mice Infected with Multidrug-Resistant Klebsiella pneumoniae ST258.
Hesse S; Malachowa N; Porter AR; Freedman B; Kobayashi SD; Gardner DJ; Scott DP; Adhya S; DeLeo FR
mBio; 2021 Feb; 12(1):. PubMed ID: 33622728
[TBL] [Abstract][Full Text] [Related]
8. Characterization of four virulent Klebsiella pneumoniae bacteriophages, and evaluation of their potential use in complex phage preparation.
Zurabov F; Zhilenkov E
Virol J; 2021 Jan; 18(1):9. PubMed ID: 33407669
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics and Time-Kill Study of Inhaled Antipseudomonal Bacteriophage Therapy in Mice.
Chow MYT; Chang RYK; Li M; Wang Y; Lin Y; Morales S; McLachlan AJ; Kutter E; Li J; Chan HK
Antimicrob Agents Chemother; 2020 Dec; 65(1):. PubMed ID: 33077657
[TBL] [Abstract][Full Text] [Related]
10. Liposome loaded phage cocktail: Enhanced therapeutic potential in resolving Klebsiella pneumoniae mediated burn wound infections.
Chadha P; Katare OP; Chhibber S
Burns; 2017 Nov; 43(7):1532-1543. PubMed ID: 28502784
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic Characterization and Efficacy of Bacteriophage Cocktails Infecting
Manohar P; Tamhankar AJ; Lundborg CS; Nachimuthu R
Front Microbiol; 2019; 10():574. PubMed ID: 30949158
[TBL] [Abstract][Full Text] [Related]
12. The therapeutic potential of bacteriophages targeting gram-negative bacteria using Galleria mellonella infection model.
Manohar P; Nachimuthu R; Lopes BS
BMC Microbiol; 2018 Aug; 18(1):97. PubMed ID: 30170558
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the efficacy of a bacteriophage in the treatment of pneumonia induced by multidrug resistance Klebsiella pneumoniae in mice.
Cao F; Wang X; Wang L; Li Z; Che J; Wang L; Li X; Cao Z; Zhang J; Jin L; Xu Y
Biomed Res Int; 2015; 2015():752930. PubMed ID: 25879036
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics/pharmacodynamics of antipseudomonal bacteriophage therapy in rats: a proof-of-concept study.
Lin YW; Chang RY; Rao GG; Jermain B; Han ML; Zhao JX; Chen K; Wang JP; Barr JJ; Schooley RT; Kutter E; Chan HK; Li J
Clin Microbiol Infect; 2020 Sep; 26(9):1229-1235. PubMed ID: 32387436
[TBL] [Abstract][Full Text] [Related]
15. Identification and complete genome of lytic "Kp34likevirus" phage vB_KpnP_Bp5 and therapeutic potency in the treatment of lethal Klebsiella pneumoniae infections in mice.
Zhang C; Yuan J; Guo C; Ge C; Wang X; Wei D; Li X; Si H; Hu C
Virus Res; 2021 May; 297():198348. PubMed ID: 33631221
[TBL] [Abstract][Full Text] [Related]
16. Bacteriophage in the treatment of experimental septicemic mice from a clinical isolate of multidrug resistant Klebsiella pneumoniae.
Vinodkumar CS; Neelagund YF; Kalsurmath S
J Commun Dis; 2005 Mar; 37(1):18-29. PubMed ID: 16637396
[TBL] [Abstract][Full Text] [Related]
17. Development of phage resistance in multidrug-resistant Klebsiella pneumoniae is associated with reduced virulence: a case report of a personalised phage therapy.
Li J; Yan B; He B; Li L; Zhou X; Wu N; Wang Q; Guo X; Zhu T; Qin J
Clin Microbiol Infect; 2023 Dec; 29(12):1601.e1-1601.e7. PubMed ID: 37652124
[TBL] [Abstract][Full Text] [Related]
18. Potential of a Bacteriophage Isolated from Wastewater in Treatment of Lobar Pneumonia Infection Induced by Klebsiella pneumoniae in Mice.
Soleimani Sasani M; Eftekhar F
Curr Microbiol; 2020 Oct; 77(10):2650-2655. PubMed ID: 32451685
[TBL] [Abstract][Full Text] [Related]
19. Characterization of
Tan D; Zhang Y; Cheng M; Le S; Gu J; Bao J; Qin J; Guo X; Zhu T
Viruses; 2019 Nov; 11(11):. PubMed ID: 31752386
[TBL] [Abstract][Full Text] [Related]
20. Phage therapy of antibiotic-resistant strains of Klebsiella pneumoniae, opportunities and challenges from the past to the future.
Mohammadi M; Saffari M; Siadat SD
Folia Microbiol (Praha); 2023 Jun; 68(3):357-368. PubMed ID: 37036571
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
